CL2022002577A1 - Aparato para eficiencia de transfeccion mejorada y/o expresion de proteina y metodo de uso del mismo. - Google Patents
Aparato para eficiencia de transfeccion mejorada y/o expresion de proteina y metodo de uso del mismo.Info
- Publication number
- CL2022002577A1 CL2022002577A1 CL2022002577A CL2022002577A CL2022002577A1 CL 2022002577 A1 CL2022002577 A1 CL 2022002577A1 CL 2022002577 A CL2022002577 A CL 2022002577A CL 2022002577 A CL2022002577 A CL 2022002577A CL 2022002577 A1 CL2022002577 A1 CL 2022002577A1
- Authority
- CL
- Chile
- Prior art keywords
- protein expression
- transfection efficiency
- improved transfection
- improved
- efficiency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Cell Biology (AREA)
- Electromagnetism (AREA)
- Sustainable Development (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004411.1A GB202004411D0 (en) | 2020-03-26 | 2020-03-26 | Apparatus and method for the application of electromagnetic signals for anti-viral transdermal and/or treatment of a medical condition |
| GBGB2004412.9A GB202004412D0 (en) | 2020-03-26 | 2020-03-26 | Method and apparatus for improvements to gene therapy |
| GBGB2009297.9A GB202009297D0 (en) | 2020-06-18 | 2020-06-18 | Method and apparatus for improvements to gene therapy |
| GBGB2009296.1A GB202009296D0 (en) | 2020-06-18 | 2020-06-18 | Apparatus and method for the application of electromagnetic signals for anti-viral, transdermal and/or direct treatment of a medical condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2022002577A1 true CL2022002577A1 (es) | 2023-07-07 |
Family
ID=75377829
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022002575A CL2022002575A1 (es) | 2020-03-26 | 2022-09-22 | Aparato para la transfeccion mejorada y/o eficiencia de suministro intracelular de un agente en una celula eucariotica y/o expresion de proteina y metodo de uso de la misma. |
| CL2022002577A CL2022002577A1 (es) | 2020-03-26 | 2022-09-22 | Aparato para eficiencia de transfeccion mejorada y/o expresion de proteina y metodo de uso del mismo. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022002575A CL2022002575A1 (es) | 2020-03-26 | 2022-09-22 | Aparato para la transfeccion mejorada y/o eficiencia de suministro intracelular de un agente en una celula eucariotica y/o expresion de proteina y metodo de uso de la misma. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20230151386A1 (es) |
| EP (2) | EP4058134A1 (es) |
| JP (2) | JP2023519316A (es) |
| KR (2) | KR20220157941A (es) |
| CN (2) | CN115315291A (es) |
| AU (2) | AU2021242028A1 (es) |
| BR (2) | BR112022017859A2 (es) |
| CA (2) | CA3163153A1 (es) |
| CL (2) | CL2022002575A1 (es) |
| GB (2) | GB2606943A (es) |
| IL (2) | IL296674A (es) |
| MX (2) | MX2022009917A (es) |
| WO (2) | WO2021191624A1 (es) |
| ZA (2) | ZA202210033B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024025825A1 (en) * | 2022-07-25 | 2024-02-01 | Mayo Foundation For Medical Education And Research | Bioreactor systems and methods for electrically stimulating cells |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6152882A (en) * | 1999-01-26 | 2000-11-28 | Impulse Dynamics N.V. | Apparatus and method for chronic measurement of monophasic action potentials |
| WO2016003485A1 (en) * | 2014-07-03 | 2016-01-07 | Massachusetts Institute Of Technology | Microfluidic assay for rapid optimization of cell electroporation |
| US11547848B2 (en) * | 2018-06-21 | 2023-01-10 | Regenesis Biomedical, Inc. | High-power pulsed electromagnetic field applicator systems |
-
2021
- 2021-03-25 MX MX2022009917A patent/MX2022009917A/es unknown
- 2021-03-25 WO PCT/GB2021/050737 patent/WO2021191624A1/en active Application Filing
- 2021-03-25 AU AU2021242028A patent/AU2021242028A1/en active Pending
- 2021-03-25 CN CN202180023774.4A patent/CN115315291A/zh active Pending
- 2021-03-25 CA CA3163153A patent/CA3163153A1/en active Pending
- 2021-03-25 US US17/912,928 patent/US20230151386A1/en active Pending
- 2021-03-25 MX MX2022009916A patent/MX2022009916A/es unknown
- 2021-03-25 IL IL296674A patent/IL296674A/en unknown
- 2021-03-25 EP EP21716525.7A patent/EP4058134A1/en active Pending
- 2021-03-25 KR KR1020227028977A patent/KR20220157941A/ko active Search and Examination
- 2021-03-25 CA CA3163155A patent/CA3163155A1/en active Pending
- 2021-03-25 IL IL296677A patent/IL296677A/en unknown
- 2021-03-25 JP JP2022558184A patent/JP2023519316A/ja active Pending
- 2021-03-25 US US17/912,932 patent/US20230159954A1/en active Pending
- 2021-03-25 BR BR112022017859A patent/BR112022017859A2/pt unknown
- 2021-03-25 KR KR1020227028982A patent/KR20220157375A/ko unknown
- 2021-03-25 GB GB2210609.0A patent/GB2606943A/en active Pending
- 2021-03-25 JP JP2022558185A patent/JP2023519317A/ja active Pending
- 2021-03-25 CN CN202180023758.5A patent/CN115361996A/zh active Pending
- 2021-03-25 EP EP21717160.2A patent/EP4058135A1/en active Pending
- 2021-03-25 BR BR112022017417A patent/BR112022017417A2/pt unknown
- 2021-03-25 WO PCT/GB2021/050736 patent/WO2021191623A1/en active Application Filing
- 2021-03-25 AU AU2021245088A patent/AU2021245088A1/en active Pending
- 2021-03-25 GB GB2210608.2A patent/GB2606942A/en active Pending
-
2022
- 2022-09-08 ZA ZA2022/10033A patent/ZA202210033B/en unknown
- 2022-09-08 ZA ZA2022/10031A patent/ZA202210031B/en unknown
- 2022-09-22 CL CL2022002575A patent/CL2022002575A1/es unknown
- 2022-09-22 CL CL2022002577A patent/CL2022002577A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230151386A1 (en) | 2023-05-18 |
| CN115361996A (zh) | 2022-11-18 |
| IL296677A (en) | 2022-11-01 |
| AU2021242028A1 (en) | 2022-07-14 |
| IL296674A (en) | 2022-11-01 |
| BR112022017859A2 (pt) | 2023-02-28 |
| KR20220157375A (ko) | 2022-11-29 |
| EP4058134A1 (en) | 2022-09-21 |
| GB2606942A (en) | 2022-11-23 |
| CA3163155A1 (en) | 2021-09-30 |
| BR112022017417A2 (pt) | 2022-11-22 |
| GB202210609D0 (en) | 2022-08-31 |
| ZA202210031B (en) | 2023-04-26 |
| GB202210608D0 (en) | 2022-08-31 |
| WO2021191623A1 (en) | 2021-09-30 |
| US20230159954A1 (en) | 2023-05-25 |
| CN115315291A (zh) | 2022-11-08 |
| JP2023519317A (ja) | 2023-05-10 |
| AU2021245088A1 (en) | 2022-07-14 |
| WO2021191624A1 (en) | 2021-09-30 |
| MX2022009917A (es) | 2022-09-09 |
| CL2022002575A1 (es) | 2023-04-21 |
| GB2606943A (en) | 2022-11-23 |
| EP4058135A1 (en) | 2022-09-21 |
| MX2022009916A (es) | 2022-09-09 |
| ZA202210033B (en) | 2023-04-26 |
| JP2023519316A (ja) | 2023-05-10 |
| CA3163153A1 (en) | 2021-09-30 |
| KR20220157941A (ko) | 2022-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020002043A1 (es) | Métodos y composiciones para la entrega de proteínas terapeuticas. | |
| CL2018003563A1 (es) | Anticuerpos anti-c5 y usos de los mismos. | |
| CL2021000704A1 (es) | Anticuerpos contra proteína alfa reguladora de señal y métodos de uso. (divisional de solicitud 668-2019) | |
| CY1124300T1 (el) | Μεθοδοι για τη χρηση αγωνιστων fxr | |
| CL2021000149A1 (es) | Composiciones anti-cd112r y métodos | |
| CR20170240A (es) | Anticuerpos anti-interleucina-33 y sus usos | |
| CR20180013A (es) | Anticuerpos anti-tau y métodos de uso. | |
| PE20180672A1 (es) | Anticuerpos anti-ctla-4 y metodos de uso de los mismos | |
| CO2018014010A2 (es) | Anticuerpos a la alfa-sinucleína y usos de los mismos | |
| CR20190271A (es) | Anticuerpos antitau y métodos de uso | |
| CL2019000729A1 (es) | Proteínas de unión recombinantes y sus usos. | |
| AR100215A1 (es) | Conjugados de anticuerpo-fármaco anti-ptk7 | |
| DK3830120T3 (da) | Hidtil ukendt fusionsprotein specifikt for cd137 og pd-l1 | |
| MX2020004801A (es) | Polipeptidos de fusion biespecificos y sus metodos de uso. | |
| CL2021000855A1 (es) | Replicones basados en alfavirus para la administración de bioterapias. | |
| CL2020002333A1 (es) | Anticuerpos anti-klk5 y métodos de uso. | |
| BR112018070497A2 (pt) | métodos e formulações farmacêuticas para tratamento de condições oculares | |
| CL2022002577A1 (es) | Aparato para eficiencia de transfeccion mejorada y/o expresion de proteina y metodo de uso del mismo. | |
| CO2020013050A2 (es) | Enzimas quinureninasa humanas y sus usos | |
| CO2022009691A2 (es) | Formulaciones líquidas de tasimelteón y métodos para su uso | |
| DOP2021000170A (es) | Formulacion de anticuerpos terapeuticos | |
| BR112019003816A2 (pt) | composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição | |
| CL2019003167A1 (es) | Proteínas de unión al antígeno anti-jagged1. | |
| CO2022002808A2 (es) | Proteínas de fusión nkg2d y sus usos | |
| AR112602A1 (es) | ANTICUERPOS ANTI-TrkB |